Paper40874151
Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy.
Ahmed NA and 5 others. RSC Adv, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy. Papers, record 40874151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40874151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References133
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35121995 | Breaking up MTDH-SND1 to break down metastasis. | Nat Cancer | 2022 | https://conductscience.org/library/papers/35121995 | PubMed |
| 2 | 33809714 | Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. | Cells | 2021 | https://conductscience.org/library/papers/33809714 | PubMed |
| 3 | 37693734 | Cheminformatics and biomolecular dynamics studies towards the discovery of anti-staphylococcal nuclease domain-containing 1 (SND1) inhibitors to treat metastatic breast cancer. | Saudi Pharm J | 2023 | https://conductscience.org/library/papers/37693734 | PubMed |
| 4 | 38758610 | Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction. | Chem Res Toxicol | 2024 | https://conductscience.org/library/papers/38758610 | PubMed |
| 5 | 36258022 | A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis. | Oncogene | 2023 | https://conductscience.org/library/papers/36258022 | PubMed |
| 6 | 38107173 | Stabilized cyclic peptides as modulators of protein-protein interactions: promising strategies and biological evaluation. | RSC Med Chem | 2023 | https://conductscience.org/library/papers/38107173 | PubMed |
| 7 | 31649842 | Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins. | Acta Pharm Sin B | 2019 | https://conductscience.org/library/papers/31649842 | PubMed |
| 8 | 38062861 | Peptide drugs: a new direction in cancer immunotherapy. | Cancer Biol Med | 2023 | https://conductscience.org/library/papers/38062861 | PubMed |
| 9 | 31111296 | Nanoparticles: Oral Delivery for Protein and Peptide Drugs. | AAPS PharmSciTech | 2019 | https://conductscience.org/library/papers/31111296 | PubMed |
| 10 | 23986882 | Tumor-penetrating peptides. | Front Oncol | 2013 | https://conductscience.org/library/papers/23986882 | PubMed |
| 11 | 35939049 | Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method. | J Chem Inf Model | 2022 | https://conductscience.org/library/papers/35939049 | PubMed |
| 12 | 31978555 | Molecular and cellular insights into the role of SND1 in lipid metabolism. | Biochim Biophys Acta Mol Cell Biol Lipids | 2020 | https://conductscience.org/library/papers/31978555 | PubMed |
| 13 | 34195230 | Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34195230 | PubMed |
| 14 | 21892917 | PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. | Curr Drug Metab | 2012 | https://conductscience.org/library/papers/21892917 | PubMed |
| 15 | 32692162 | Challenges and Opportunities in Cancer Drug Resistance. | Chem Rev | 2021 | https://conductscience.org/library/papers/32692162 | PubMed |
| 16 | 22437869 | Combining immunotherapy and targeted therapies in cancer treatment. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22437869 | PubMed |
| 17 | 32645525 | A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. | Genomics | 2020 | https://conductscience.org/library/papers/32645525 | PubMed |
| 18 | 25112216 | Cell penetration: scope and limitations by the application of cell-penetrating peptides. | J Pept Sci | 2014 | https://conductscience.org/library/papers/25112216 | PubMed |
| 19 | 35609735 | MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy. | Cancer Lett | 2022 | https://conductscience.org/library/papers/35609735 | PubMed |
| 20 | 35656714 | Structural landscapes of PPI interfaces. | Brief Bioinform | 2022 | https://conductscience.org/library/papers/35656714 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883989 | Computational Investigation of S781F Mutation-Induced Remodeling of the Staphylococcal Nuclease Domain-Containing Protein 1-Argonaute 2 Interface. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883989 | PubMed |
| 42611115 | Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein-protein interaction disruptors of the HEG1-KRIT1 interface. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42611115 | PubMed |
| 42210006 | 1H-Indazole-3-Carboxylic Acid Derivatives as Disruptors of the Oncogenic MTDH-SND1 Protein-Protein Interaction: An In Silico-to-In Vitro Study. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/42210006 | PubMed |
| 41563710 | AEG-1/MTDH Enhances Hepatocellular Carcinoma Radioresistance by Recruiting PTBP1 Via SND1 To Stabilize ATG5 mRNA and Promote Protective Autophagy. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41563710 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| MTDH | 92140 | PubTator's text mining | https://conductscience.org/library/genes/92140 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| SND1 | 27044 | PubTator's text mining | https://conductscience.org/library/genes/27044 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40874151
GET https://conductscience.org/api/papers/v1/40874151/references?page=2